David A. Reardon
- Genetics top 0.01%
- Molecular Biology top 0.2%
- Oncology top 0.1%
- Pulmonary and Respiratory Medicine top 0.1%
- Cancer Research top 0.05%
- Co-authors
- Henry S. FriedmanDarell D. BignerJames E. HerndonPatrick Y. WenAllan H. FriedmanJohn H. SampsonJames J. VredenburghAnnick Desjardins
- Topics
- Glioma Diagnosis and Treatment (406 papers)Brain Metastases and Treatment (111 papers)Cancer Immunotherapy and Biomarkers (82 papers)
- Cited by
- GeneticsCancer ResearchOncology
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
David A. Reardon
544 papers receiving 33.5k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Genetics 20.8k
- Molecular Biology 10.4k
- Oncology 8.7k
- Pulmonary and Respiratory Medicine 7.3k
- Cancer Research 7.2k
Countries citing papers authored by David A. Reardon
This map shows the geographic impact of David A. Reardon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Reardon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Reardon more than expected).
Fields of papers citing papers by David A. Reardon
This network shows the impact of papers produced by David A. Reardon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Reardon. The network helps show where David A. Reardon may publish in the future.
Co-authorship network of co-authors of David A. Reardon
This figure shows the co-authorship network connecting the top 25 collaborators of David A. Reardon. A scholar is included among the top collaborators of David A. Reardon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Reardon. David A. Reardon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 4 | |
| 5 | 27 | |
| 6 | 6 | |
| 7 | 104 | |
| 8 | 18 | |
| 9 | 42 | |
| 10 | 56 | |
| 11 | 49 | |
| 12 | 10 | |
| 13 | 302 | |
| 14 | 91 | |
| 15 | 29 | |
| 16 | 94 | |
| 17 | 112 | |
| 18 | Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastomabreakdown → | 613 |
| 19 | 221 | |
| 20 | 130 |
About David A. Reardon
David A. Reardon is a scholar working on Genetics, Oncology and Cancer Research, having authored 560 papers that have together received 34.0k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (406 papers), Brain Metastases and Treatment (111 papers) and Cancer Immunotherapy and Biomarkers (82 papers). The work is most often cited by research in Genetics (20.8k citations), Cancer Research (7.2k citations) and Oncology (8.7k citations). David A. Reardon has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Henry S. Friedman, Darell D. Bigner, James E. Herndon, Patrick Y. Wen, Allan H. Friedman, John H. Sampson, James J. Vredenburgh, Annick Desjardins, Roger E. McLendon and Jeremy N. Rich. Their work appears in journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.